---
figid: PMC4653963__austprescr-38-074-f1
figtitle: Action of BRAF and MEK inhibitors in the MAP kinase signalling pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4653963
filename: austprescr-38-074-f1.jpg
figlink: /pmc/articles/PMC4653963/figure/f1/
number: F1
caption: Action of BRAF and MEK inhibitors in the MAP kinase signalling pathway
papertitle: Medical management of malignant melanoma.
reftext: Victoria Atkinson. Aust Prescr. 2015 Jun;38(3):74-78.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9125235
figid_alias: PMC4653963__F1
figtype: Figure
redirect_from: /figures/PMC4653963__F1
ndex: c25d1f4d-deb9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4653963__austprescr-38-074-f1.html
  '@type': Dataset
  description: Action of BRAF and MEK inhibitors in the MAP kinase signalling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - mapP
  - rl
  - C15
  - Cli
  - eya
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SGSM3
  - MAPK3
  - MAPK1
  - DCLK1
  - ADGRL1
  - CLU
  - AKR1C4
  - GZMB
  - POLR3K
  - trametinib
  - dabrafenib
  - cobimetinib
---
